|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||298.52 - 300.05|
|52-week range||298.52 - 300.05|
|Beta (5Y monthly)||0.75|
|PE ratio (TTM)||24.80|
|Earnings date||21 Feb 2022 - 25 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Masimo (MASI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
IRVINE, Calif., November 23, 2021--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Piper Sandler 33rd Annual Healthcare Conference on Tuesday, November 30, 2021 at 2:00 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation.
The study findings show that monitoring with Masimo (MASI) SedLine Brain Function Monitoring parameters during CEA surgery can reduce the risk of postoperative delirium.